Headline News about Sanofi-Aventis S.A. ADR
Sanofi's Earnings Outlook
January 31, 2024
Via Benzinga
Looking Into Sanofi's Recent Short Interest
December 21, 2023
Via Benzinga
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|